Vital Therapies, Inc. (VTL) insiders have most recently took part in a trading activity. On Jun 14, 2017 Winters Terence E., Co-Chairman and CEO bought 10,000 shares having total worth of $31,000 at the price of $3.1 per share, following the transaction a total of 314,930 shares owned by Winters Terence E..
On Jun 13, 2017 Bienaime Jean Jacques, Director bought 16,000 shares having total worth of $48,000 at the price of $3 per share, following the transaction a total of 55,119 shares owned by Bienaime Jean Jacques.
The stock has experienced a total of 5 insider trades in the past three months. These trades include 5 buy trades. Furthermore, over the past 12 months , the stock was traded 6 times by insiders. an employee of the company was the buyer in 6 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Vital Therapies, Inc. (VTL) traded up 3.33% on Jun 14, 2017, hitting $3.1. 121,274 shares of the company’s stock traded hands. Vital Therapies, Inc. has a 52 week low of $2.5 and a 52 week high of $10.53. The company’s market cap is $195 million.
Vital Therapies, Inc. (VTL) last announced its earnings results on May 9, 2017. The company reported -0.39 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.37 by $0.02. During the same quarter in the previous year, the company posted -0.31 earnings per share.
|earnings per share||-0.39||-0.37||-0.32||-0.31||-0.34||-0.51||-0.63||-0.62||-0.59||-0.59|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018